This content is from: Premium

Baupost Goes Long on Health Care

Seth Klarman’s Boston-based firm counted three small drug companies among its ten largest positions last quarter and recently revealed new positions in the sector.

       Seth Klarman, Baupost Group (Bloomberg)Famed value investor Seth Klarman’s Baupost Group is exploring a new investing theme, building a portfolio of fledgling pharmaceutical companies. In the past month or two, the Boston-based investment firm has disclosed at least three new positions in smallish pharmaceutical companies. In addition, three of its ten

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content